-
Taurodeoxychloic Acid sodium hydrate
- names:
Taurodeoxychloic Acid sodium hydrate
- CAS号:
110026-03-4
MDL Number: - MF(分子式): C26H47NNaO7S+ MW(分子量): 540.71
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM001450-50mg | 50mg | >98.0% | ¥ 1890.00 | ¥ 1890.00 | 2-3天 | ¥ 0.00 | ||
| YZM001450-10mg | 10mg | >98.0% | ¥ 650.00 | ¥ 650.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | Taurodeoxychloic Acid sodium hydrate |
| CAS号 | 110026-03-4 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C26H47NNaO7S+ |
| 分子量 Molecular Weight | 540.71 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度125 mg/mL(231.18 mM;Need ultrasonic) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
| 产品说明 | |
| Introduction | Taurodeoxychloic Acid (sodium hydrate) prevents apoptosis by blocking a calciumediated apoptotic pathway as well as caspase2 activation. Taurodeoxychloic Acid (sodium hydrate) is investigated for use in several conditions such as Primary Biliary Cirrhosis (PBC), insulin resistance, amyloidosis, Cystic Fibrosis, Cholestasis, and Amyotrophic Lateral Sclerosis. |
| Application1 | |
| Application2 | |
| Application3 |
Taurodeoxychloic Acid (sodium hydrate) prevents apoptosis by blocking a calcium-mediated apoptotic pathway as well as caspase-12 activation. Taurodeoxychloic Acid (sodium hydrate) is investigated for use in several conditions such as Primary Biliary Cirrhosis (PBC), insulin resistance, amyloidosis, Cystic Fibrosis, Cholestasis, and Amyotrophic Lateral Sclerosis[1].
【1】.Xie Q, et al. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology. 2002 Sep;36(3):592-601.
【2】.Keene CD, et al. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10671-6.
【2】.Keene CD, et al. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10671-6.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


